KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Accumulated Expenses (2016 - 2026)

Emergent BioSolutions has reported Accumulated Expenses over the past 17 years, most recently at $9.4 million for Q1 2026.

  • For Q1 2026, Accumulated Expenses fell 28.79% year-over-year to $9.4 million; the TTM value through Mar 2026 reached $9.4 million, down 28.79%, while the annual FY2025 figure was $12.2 million, 78.25% down from the prior year.
  • Accumulated Expenses for Q1 2026 was $9.4 million at Emergent BioSolutions, down from $12.2 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $87.3 million in Q4 2022 and troughed at $9.4 million in Q1 2026.
  • A 5-year average of $34.3 million and a median of $31.2 million in 2023 define the central range for Accumulated Expenses.
  • On a YoY basis, Accumulated Expenses climbed as much as 83.14% in 2025 and fell as far as 78.25% in 2025.
  • Year by year, Accumulated Expenses stood at $87.3 million in 2022, then dropped by 15.12% to $74.1 million in 2023, then dropped by 24.29% to $56.1 million in 2024, then tumbled by 78.25% to $12.2 million in 2025, then decreased by 22.95% to $9.4 million in 2026.
  • Business Quant data shows Accumulated Expenses for EBS at $9.4 million in Q1 2026, $12.2 million in Q4 2025, and $13.9 million in Q3 2025.